U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583446) titled 'Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock' on May 01.
Brief Summary: The goal of this clinical trial is to learn if the drug istaroxime works to treat mild to moderate cardiogenic shock due to acute heart failure in adults. It will also learn about the safety of istaroxime. The main questions it aims to answer are:
* Does istaroxime relieve participants' shortness of breath compared to a placebo?
* Does istaroxime provide clinical benefit in terms of lowering the risk of dying, having invasive procedures, having worsening heart failure, and/or increasing quality of life compared ...